1. What Does a Canine DNA Test Actually Test?

A DNA test usually analyzes a particular location in the dog’s genome for a known variant. Depending on the test, the laboratory may use blood, a cheek swab, or another biological sample.

• Clear: the tested disease-associated variant was not detected.
• Carrier: one copy of a recessive variant was detected.
• Affected, at risk, or genetically affected: the relevant number of variant copies was detected under the test’s inheritance model.
• Indeterminate: the sample or result could not be interpreted reliably.

Hundreds of canine Mendelian disease and trait variants have been described, but researchers continue to evaluate their frequency and clinical effect across different breeds and ancestry backgrounds. A study of more than one million dogs found that variant prevalence and relevance vary substantially, making breed and ancestry context essential to interpretation.¹

2. Why DNA Tests Do Not Apply Equally to Every Breed

Breed formation created different genetic populations

Modern breeds were shaped through selective breeding, population bottlenecks, restricted gene flow, and repeated use of influential sires. These practices created recognizable breed traits, but also concentrated different variants within different populations.

• Some variants occur mainly in one breed, line, or family.
• Some ancient variants occur across numerous breeds.
• Different variants can cause similar diseases in different breeds.
• A variant associated with disease in one breed may have uncertain significance in another.
• A breed may experience a hereditary disease whose causal variant has not yet been identified.

Finding a variant in a new breed does not prove it causes the same disease in that breed. Researchers must determine whether the genotype corresponds with the expected clinical condition in that population. Large-scale studies caution against decisive healthcare or breeding decisions when the effect has not been established in the dog’s ancestry background.^1,2

One disease name can have several genetic causes

Progressive retinal atrophy, spinocerebellar ataxia, cystinuria, and other conditions can be genetically heterogeneous. Different variants—sometimes in different genes—may produce similar clinical signs. A dog may test clear for one retinal variant while remaining susceptible to another known variant, an undiscovered variant, a different inherited disorder, or an acquired eye disease. Researchers emphasize that discovering a variant in an additional breed must be followed by evidence connecting that genotype with the phenotype in the new genetic background.³

3. Detection Is Not the Same as Clinical Meaning

A test may be analytically accurate while its clinical importance remains uncertain in a particular breed. Published laboratory standards call for evidence supporting the variant-disease relationship, appropriate assay validation, and continuing review.⁴

4. Understanding Modes of Inheritance

Autosomal recessive conditions

Under a conventional autosomal recessive model, a carrier has one normal copy and one variant copy. When two carriers are bred, each puppy has an expected 25% chance of inheriting two clear copies, 50% chance of being a carrier, and 25% chance of inheriting two variant copies. These are probabilities for every puppy, not a promised distribution across one litter.

Autosomal dominant conditions

One copy of a dominant disease-associated variant may create risk. The strength of that prediction depends on penetrance, age of onset, variable expression, and the evidence supporting the test.

X-linked conditions

Risk differs between males and females because males have one X chromosome and females have two. Interpretation therefore depends on the dog’s sex and the particular disorder.

Complex and polygenic conditions

Many important diseases involve multiple genes and interactions with age, nutrition, body condition, hormones, activity, and environment. A single marker may indicate increased risk without determining the outcome.

5. Penetrance: Why “At Risk” Does Not Always Mean “Will Become Sick”

Penetrance describes the proportion of dogs with a genotype that develop the associated condition. With incomplete penetrance, some dogs with the genotype develop disease and others do not. Differences can reflect modifier genes, age of onset, environmental influences, sex-related effects, ancestry, diagnostic criteria, or uncertainty in the original association.

The commonly tested SOD1 variant associated with degenerative myelopathy appears across many breeds, yet not every genetically at-risk dog develops clinical disease. Laboratory-guideline authors cite it as an example requiring careful interpretation rather than assuming identical effects in every dog.²

6. Expressivity: Similar Genotypes, Different Outcomes

Variable expressivity means dogs sharing a genotype may have different ages of onset, severity, progression, complications, and responses to treatment. Even when a variant is disease-causing, DNA alone may not predict when signs will appear or how severely an individual will be affected.

7. Phenocopies and Alternative Causes

A phenocopy occurs when a dog develops signs resembling a genetic condition through another genetic cause, an acquired condition, or an environmental influence. A dog can test clear for a known retinal variant and still lose vision because of another inherited retinal condition, trauma, inflammation, infection, toxicity, or aging. Researchers have called for disclosure of known phenocopies and variant-specific limitations.⁵

8. Breed-Specific Tests Versus All-Breed Panels

Breed-specific recommendations focus on variants and screening procedures considered relevant to a population. The OFA/CHIC program works with participating parent clubs to identify recommended screening protocols, while recognizing that the lists may not include every concern.^6,7

Large panels can be useful for mixed-breed dogs, variants found across several breeds, unexpected ancestry, research, or efficient screening of several established risks. But a longer report is not automatically a better health evaluation. It may include irrelevant conditions, variants with uncertain relevance, trait results unrelated to health, preliminary associations, or tests that do not replace breed-recommended physical screening.

The WSAVA/PennGen database organizes available tests by breed, disease, and laboratory and connects tests with mutation research.⁸

9. Why a “Clear Panel” Is Not a Complete Health Clearance

A dog can be clear for every variant on a panel and still carry an untested or undiscovered variant, develop a polygenic or structural condition, or acquire an illness. DNA testing does not replace veterinary examinations, cardiac or eye evaluation, orthopedic imaging, laboratory testing, specialist consultation, or family-history analysis.

10. Carrier Does Not Automatically Mean Unhealthy

For a well-established autosomal recessive disorder, a carrier ordinarily has one normal copy and one variant copy. Carriers can often be bred responsibly to tested clear partners without producing puppies genetically affected by that condition.

Automatically removing every carrier can reduce diversity, particularly when a variant is common in a small population. Researchers recommend balancing disease reduction with preservation of healthy genetic diversity rather than treating every carrier as unsuitable.^5,9

The whole dog must still be evaluated for physical health, temperament, structure, family history, other risks, relationship to the proposed mate, and the needs of the breed population. The goal is to avoid affected puppies without unnecessarily shrinking the gene pool.

11. When a Result Should Be Confirmed

Confirmation may be appropriate when a result is unexpected for the breed, conflicts with prior testing, depends on uncertain sample identity, will drive a major decision, comes from a laboratory with unclear validation, conflicts with the dog’s clinical signs, or has uncertain relevance in that ancestry.

1. Repeat the test using a new sample.
2. Use an independent laboratory.
3. Order a targeted test for the named variant.
4. Confirm identity and parentage.
5. Consult a veterinarian or veterinary genetics professional.
6. Perform appropriate examination, laboratory testing, imaging, or specialist evaluation.
7. Review the evidence connecting that variant with disease in that breed.

12. Questions Puppy Buyers Should Ask

1. Which dog does the report belong to?
2. How was identity verified?
3. Which laboratory performed the test?
4. Which exact variants were evaluated?
5. Are they relevant to this breed?
6. Is the association peer reviewed?
7. What is the inheritance pattern?
8. Is penetrance complete or incomplete?
9. Does “at risk” predict disease or susceptibility?
10. Were both parents tested?
11. Were non-DNA screenings completed?
12. May I review the original report?
13. Does the result require confirmation?
14. How did the breeder use it in selecting the mating?

Conclusion

Canine DNA testing is powerful when it answers a specific, scientifically supported question. It can identify variants, clarify inheritance, help avoid affected matings, support research, and guide follow-up. It cannot certify complete health, replace veterinary examinations, detect every genetic disorder, or predict every dog’s future.